⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6336160 | 0.81 | — | — | |
| SCHEMBL7524031 | 0.79 | — | — | |
| SCHEMBL3021594 | 0.77 | — | — | |
| SCHEMBL3033812 | 0.77 | ALDH1A1 (0.39) | — | |
| SCHEMBL10904780 | 0.77 | ALDH1A1 (0.39) | — | |
| SCHEMBL10887342 | 0.77 | ALDH1A1 (0.39) | — | |
| SCHEMBL11319609 | 0.72 | LPAR3 (0.30) | — | |
| SCHEMBL7773058 | 0.72 | LPAR3 (0.30) | — | |
| SCHEMBL310640 | 0.72 | — | — | |
| SCHEMBL778646 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7598244-B2 | [1,2,4]triazolo[1,5,a]pyrimidin-2-ylurea derivative and use thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-10-06 | — | — | US | claimed |
| US-12030868-B2 | Prodrugs of CGRP antagonists | PFIZER IRELAND PHARMACEUTICALS (IE) | 2024-07-09 | — | — | US | disclosed |
| US-20240067651-A1 | PRODRUGS OF MYELOPEROXIDASE INHIBITORS | BIOHAVEN THERAPEUTICS LTD. | 2024-02-29 | — | — | US | disclosed |
| EP-4289810-A1 | METHOD FOR PRODUCING (2-METHOXYETHYL) VINYL ETHER, AND METHOD FOR REFINING (2-METHOXYETHYL) VINYL ETHER | Maruzen Petrochemical Co., Ltd. (JP) | 2023-12-13 | — | — | EP | disclosed |
| CN-114945573-A | Prodrugs of myeloperoxidase inhibitors | 拜奥海芬治疗学有限公司 | 2022-08-26 | — | — | CN | disclosed |
| US-20210395223-A1 | PRODRUGS OF CGRP ANTAGONISTS | PFIZER IRELAND PHARMACEUTICALS (IE) | 2021-12-23 | — | — | US | disclosed |
| EP-3863629-A1 | PRODRUGS OF CGRP ANTAGONISTS | Biohaven Pharmaceutical Holding Company Ltd. (US) | 2021-08-18 | — | — | EP | disclosed |
| CN-112888438-A | Prodrugs of CGRP antagonists | 拜尔哈文制药股份有限公司 | 2021-06-01 | — | — | CN | disclosed |
| WO-2021072140-A1 | PRODRUGS OF MYELOPEROXIDASE INHIBITORS | BIOHAVEN THERAPEUTICS LTD. (US) | 2021-04-15 | — | — | WO | disclosed |
| EP-3514133-B1 | METHOD FOR REMOVING OR COLLECTING 2-ALKOXYETHANOL, AND METHOD FOR PRODUCING (2-ALKOXYETHYL) VINYL ETHER | MARUZEN PETROCHEM CO LTD (JP) | 2020-11-25 | — | — | EP | disclosed |
| EP-0872484-A1 | ORGANOSILICON COMPOUNDS, LIQUID-CRYSTAL COMPOSITION, AND LIQUID-CRYSTAL DISPLAY ELEMENT | CHISSO CORPORATION (JP) | 1998-10-21 | — | — | EP | disclosed |
| EP-0559860-B1 | HALOVINYL-DERIVATIVES | HOFFMANN LA ROCHE (CH) | 1996-02-14 | — | — | EP | disclosed |
| US-5364556-A | Halovinyl-derivatives | HOFFMANN-LA ROCHE INC. (US) | 1994-11-15 | — | — | US | disclosed |
| EP-0430001-B1 | Process for preparing benzaldehydes | BAYER AG (DE) | 1993-12-22 | — | — | EP | disclosed |
| WO-1993007234-A1 | HALOVINYL-DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1993-04-15 | — | — | WO | disclosed |
| US-5082976-A | PROCESS FOR THE PREPARATION OF BENZALDEHYDES | BAYER AKTIENGESELLSCHAFT (DE) | 1992-01-21 | — | — | US | disclosed |
| EP-0430001-A1 | Process for preparing benzaldehydes | BAYER AG (DE) | 1991-06-05 | — | — | EP | disclosed |
| EP-0192242-B1 | SUBSTITUTED AMINOPHENYLUREA DERIVATIVES | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1990-11-07 | — | — | EP | disclosed |
| US-4803223-A | ANTITUMOR AGENTS | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1989-02-07 | — | — | US | disclosed |
| EP-0192242-A1 | Substituted aminophenylurea derivatives | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1986-08-27 | — | — | EP | disclosed |